{"id":381,"date":"2024-02-06T14:33:18","date_gmt":"2024-02-06T14:33:18","guid":{"rendered":"https:\/\/smartdrugs2024.com\/?page_id=381"},"modified":"2024-03-11T13:20:07","modified_gmt":"2024-03-11T13:20:07","slug":"poot-team","status":"publish","type":"page","link":"https:\/\/smartdrugs2024.com\/?page_id=381","title":{"rendered":"Poot Team &#8211; UMCU"},"content":{"rendered":"\n<h4 class=\"wp-block-heading alignwide\">Dr. Alex Poot<\/h4>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center\" style=\"grid-template-columns:18% auto\"><figure class=\"wp-block-media-text__media\"><img data-opt-id=1243955755  fetchpriority=\"high\" decoding=\"async\" width=\"635\" height=\"885\" src=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:auto\/h:auto\/q:mauto\/ig:avif\/http:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/01\/4-alex.png\" alt=\"\" class=\"wp-image-135 size-full\" srcset=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:635\/h:885\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/01\/4-alex.png 635w, https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:215\/h:300\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/01\/4-alex.png 215w\" sizes=\"(max-width: 635px) 100vw, 635px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p><\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><a href=\"https:\/\/orcid.org\/0000-0002-4226-7630\"><img data-opt-id=395480196  fetchpriority=\"high\" decoding=\"async\" width=\"512\" height=\"166\" src=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:auto\/h:auto\/q:mauto\/ig:avif\/http:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/02\/Picture-1.png\" alt=\"\" class=\"wp-image-338\" style=\"width:130px\" srcset=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:512\/h:166\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/02\/Picture-1.png 512w, https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:300\/h:97\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/02\/Picture-1.png 300w\" sizes=\"(max-width: 512px) 100vw, 512px\" \/><\/a><\/figure>\n<\/div><\/div>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading alignwide\">Dr. Berend van der Wildt<\/h4>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center\" style=\"grid-template-columns:18% auto\"><figure class=\"wp-block-media-text__media\"><img data-opt-id=1396481831  data-opt-src=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:auto\/h:auto\/q:mauto\/ig:avif\/http:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/03\/Berend_crop.png\"  decoding=\"async\" width=\"591\" height=\"831\" src=\"data:image/svg+xml,%3Csvg%20viewBox%3D%220%200%20100%%20100%%22%20width%3D%22100%%22%20height%3D%22100%%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Crect%20width%3D%22100%%22%20height%3D%22100%%22%20fill%3D%22transparent%22%2F%3E%3C%2Fsvg%3E\" alt=\"\" class=\"wp-image-727 size-full\" old-srcset=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:591\/h:831\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/03\/Berend_crop.png 591w, https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:213\/h:300\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/03\/Berend_crop.png 213w\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Berend van der Wildt obtained his PhD in Radiopharmaceutical Sciences in 2017 at the Amsterdam University Medical Center where he developed small molecule PET tracers targeting tissue transglutaminase. He continued his career at Stanford University as a post-doctoral researcher designing PET tracers for imaging of tumor associated macrophages in neuro-oncology. In 2019, after obtaining a VENI grant from the Dutch Research Council, Berend returned to the Amsterdam University Medical Center where he focused on developing PET tracers specific for anti-inflammatory microglia in neuro-oncology and neuroinflammation. Currently, Berend has a position at the UMC Utrecht and Princess M\u00e1xima Center as a post-doctoral researcher where, under the direct supervision of Dr. Alex Poot, he is establishing a preclinical theranostics research line towards improved treatment of pediatric and adult cancers.&nbsp;<\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h4 class=\"wp-block-heading alignwide\">Carlijn Vlaswinkel (PhD candidate &#8211; Funded by SMARTdrugs)<\/h4>\n\n\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:18% auto\"><figure class=\"wp-block-media-text__media\"><img data-opt-id=752379376  data-opt-src=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:auto\/h:auto\/q:mauto\/ig:avif\/http:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/03\/Carljin_crop.png\"  decoding=\"async\" width=\"587\" height=\"829\" src=\"data:image/svg+xml,%3Csvg%20viewBox%3D%220%200%20100%%20100%%22%20width%3D%22100%%22%20height%3D%22100%%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Crect%20width%3D%22100%%22%20height%3D%22100%%22%20fill%3D%22transparent%22%2F%3E%3C%2Fsvg%3E\" alt=\"\" class=\"wp-image-728 size-full\" old-srcset=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:587\/h:829\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/03\/Carljin_crop.png 587w, https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:212\/h:300\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/03\/Carljin_crop.png 212w\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Carlijn obtained a master\u2019s degree in Biomedical Sciences at Maastricht University in 2022. During her studies, she specialised in Immunology and Pathophysiology and performed research investigating the biological activity of anti-cancer therapeutics secreted by a genetically modified strain of an anaerobic bacterium called&nbsp;<em>Clostridium sporogenes<\/em>. After her studies, she worked as a Quality Control technician in a cell therapy production facility at the Dutch Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) for one year. Carlijn recognized she wanted to get back into academic research and started her PhD position in March 2024 under supervision of Dr. Alex Poot and Dr. Berend van der Wildt. Carlijn will focus on the pre-clinical validation of the supra-molecular designs using&nbsp;<em>in vitro&nbsp;<\/em>cellular and tissue assays and&nbsp;<em>in vivo<\/em>&nbsp;mouse models of paediatric brain cancers.<\/p>\n<\/div><\/div>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-group alignfull has-contrast-color has-text-color is-vertical is-content-justification-center is-layout-flex wp-container-core-group-layout-1 wp-block-group-is-layout-flex\" style=\"min-height:40vh;margin-top:0;margin-bottom:0;padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--50);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--50)\"><div style=\"margin-bottom:6px;\" class=\"is-default-size aligncenter wp-block-site-logo\"><a href=\"https:\/\/smartdrugs2024.com\/\" class=\"custom-logo-link\" rel=\"home\"><img data-opt-id=1567365148  data-opt-src=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:auto\/h:auto\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/01\/Smart_drug_logo.png\"  decoding=\"async\" width=\"716\" height=\"520\" src=\"data:image/svg+xml,%3Csvg%20viewBox%3D%220%200%20100%%20100%%22%20width%3D%22100%%22%20height%3D%22100%%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Crect%20width%3D%22100%%22%20height%3D%22100%%22%20fill%3D%22transparent%22%2F%3E%3C%2Fsvg%3E\" class=\"custom-logo\" alt=\"smartdrugs2024.com\" old-srcset=\"https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:716\/h:520\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/01\/Smart_drug_logo.png 716w, https:\/\/mlpq7ncp5jqb.i.optimole.com\/w:300\/h:218\/q:mauto\/ig:avif\/https:\/\/smartdrugs2024.com\/wp-content\/uploads\/2024\/01\/Smart_drug_logo.png 300w\" \/><\/a><\/div>\n\n\n<p class=\"has-text-align-center has-medium-font-size\">Proudly powered by <a href=\"https:\/\/wordpress.org\">WordPress<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Alex Poot Dr. Berend van der Wildt Berend van der Wildt obtained his PhD in Radiopharmaceutical Sciences in 2017 at the Amsterdam University Medical Center where he developed small molecule PET tracers targeting tissue transglutaminase. He continued his career at Stanford University as a post-doctoral researcher designing PET tracers [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"_links":{"self":[{"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=\/wp\/v2\/pages\/381"}],"collection":[{"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=381"}],"version-history":[{"count":16,"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=\/wp\/v2\/pages\/381\/revisions"}],"predecessor-version":[{"id":729,"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=\/wp\/v2\/pages\/381\/revisions\/729"}],"wp:attachment":[{"href":"https:\/\/smartdrugs2024.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}